| Current diagnosis and management of small-cell lung cancer S Wang, S Zimmermann, K Parikh, AS Mansfield, AA Adjei Mayo Clinic Proceedings 94 (8), 1599-1622, 2019 | 227 | 2019 |
| Selective inhibitors of nuclear export (SINE)–a novel class of anti-cancer agents K Parikh, S Cang, A Sekhri, D Liu Journal of hematology & oncology 7, 1-8, 2014 | 151 | 2014 |
| Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors J Ahmed, A Kumar, K Parikh, A Anwar, BM Knoll, C Puccio, H Chun, ... Oncoimmunology 7 (11), e1507670, 2018 | 138 | 2018 |
| Selective inhibitors of nuclear export (SINE) in hematological malignancies A Das, G Wei, K Parikh, D Liu Experimental hematology & oncology 4, 1-4, 2015 | 66 | 2015 |
| Drugging KRAS: current perspectives and state-of-art review K Parikh, G Banna, SV Liu, A Friedlaender, A Desai, V Subbiah, A Addeo Journal of hematology & oncology 15 (1), 152, 2022 | 54 | 2022 |
| Tumor mutational burden from tumor-only sequencing compared with germline subtraction from paired tumor and normal specimens K Parikh, R Huether, K White, D Hoskinson, N Beaubier, H Dong, ... JAMA Network Open 3 (2), e200202-e200202, 2020 | 46 | 2020 |
| Hypertension and renin–angiotensin–aldosterone system inhibitors in patients with Covid-19 A Ip, K Parikh, JE Parrillo, S Mathura, E Hansen, IS Sawczuk, ... MedRxiv, 2020.04. 24.20077388, 2020 | 42 | 2020 |
| Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer K Parikh, A Kumar, J Ahmed, A Anwar, C Puccio, H Chun, M Fanucchi, ... Cancer Immunology, Immunotherapy 67, 1365-1370, 2018 | 31 | 2018 |
| Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups YW Asmann, K Parikh, PL Bergsagel, H Dong, AA Adjei, MJ Borad, ... NPJ precision oncology 5 (1), 22, 2021 | 26 | 2021 |
| Cardiac immune-related adverse events in immune checkpoint inhibition therapy AD Brumbaugh, R Narurkar, K Parikh, M Fanucchi, WH Frishman Cardiology in review 27 (2), 97-107, 2019 | 26 | 2019 |
| The forgotten disease: Bilateral lemierre’s disease with mycotic aneurysm of the vertebral artery T Gupta, K Parikh, S Puri, S Agrawal, N Agrawal, D Sharma, L DeLorenzo The American journal of case reports 15, 230, 2014 | 24 | 2014 |
| Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective D Liu, D Mehta, S Kaur, A Kumar, K Parikh, L Chawla, S Patel, A Devi, ... Journal of Hematology & Oncology 11, 1-9, 2018 | 20 | 2018 |
| Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study P Ram, A Tiu, KB Lo, K Parikh, M Shah Heart Failure Reviews 24 (6), 989-995, 2019 | 15 | 2019 |
| Recent advances in the management of smoldering multiple myeloma BR Madhira, VM Konala, S Adapa, S Naramala, PM Ravella, K Parikh, ... World journal of oncology 11 (2), 45, 2020 | 9 | 2020 |
| Use of therapeutic hypothermia among patients with coagulation disorders–a Nationwide analysis M Shah, K Parikh, B Patel, M Agarwal, L Garg, S Agrawal, S Arora, ... Resuscitation 124, 35-42, 2018 | 9 | 2018 |
| Increased mortality among patients with acute leukemia admitted on weekends compared to weekdays K Parikh, M Shah, D Mehta, S Arora, N Patel, D Liu Clinical Lymphoma Myeloma and Leukemia 17 (12), e33-e43, 2017 | 7 | 2017 |
| Isolated factor V deficiency in a patient with elevated PT and aPTT during routine pre-operative laboratory screening K Thakar, K Parikh, Y Chen, D Liu Stem Cell Investigation 1, 2014 | 7 | 2014 |
| Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges K Parikh, LEL Hendriks, P Bironzo, J Remon Cancer Treatment Reviews 99, 102250, 2021 | 6 | 2021 |
| Beyond crizotinib: a systematic review and meta-analysis of the next-generation ALK inhibitors as first-line treatment for ALK-translocated lung cancer EF Giunta, A Signori, HJ West, G Metro, A Friedlaender, K Parikh, ... Frontiers in Oncology 12, 921854, 2022 | 5 | 2022 |
| Changing paradigm in advanced and metastatic non-small cell lung cancer D Uprety, K Parikh, A Sawkar, A Dimou, K Leventakos Journal of Thoracic Disease 12 (11), 6992, 2020 | 5 | 2020 |
